Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helena Furberg

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
International Journal of Cancer|May 31, 2021
Differences in risk factors for molecular subtypes of clear cell renal cell carcinomaMark P Purdue, Jongeun Rhee, Lee Moore, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
European Urology|December 5, 2012
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomyMichael Rink, Emily C Zabor, Helena Furberg, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint BlockadeYasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in CancerSabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder CancerJeffrey S Damrauer, Kyle R Roell, Markia A Smith, et al.
Journal of Oncology|October 30, 2009
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American WomenChristine B Ambrosone, Gregory L Ciupak, Elisa V Bandera, et al.
Ebiomedicine|March 17, 2016
Gene by Environment Investigation of Incident Lung Cancer Risk in African-AmericansSean P David, Ange Wang, Kristopher Kapphahn, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|May 31, 2021
Differences in risk factors for molecular subtypes of clear cell renal cell carcinomaMark P Purdue, Jongeun Rhee, Lee Moore, et al.
BMC Medical Research Methodology|December 24, 2014
Genomic investigation of etiologic heterogeneity: methodologic challengesColin B Begg, Venkatraman E Seshan, Emily C Zabor, et al.
European Urology|December 5, 2012
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomyMichael Rink, Emily C Zabor, Helena Furberg, et al.
The Lancet. Oncology|December 25, 2019
Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort studyAlejandro Sanchez, Helena Furberg, Fengshen Kuo, et al.
Journal of the National Cancer Institute|November 29, 2013
An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinomaA Ari Hakimi, Helena Furberg, Emily C Zabor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
Associations between Pretreatment Body Composition Features and Clinical Outcomes among Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint BlockadeYasser Ged, Alejandro Sanchez, Sujata Patil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in CancerSabine Topka, Zoe Steinsnyder, Vignesh Ravichandran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2021
Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non-Muscle-Invasive Bladder CancerJeffrey S Damrauer, Kyle R Roell, Markia A Smith, et al.
Journal of Oncology|October 30, 2009
Conducting Molecular Epidemiological Research in the Age of HIPAA: A Multi-Institutional Case-Control Study of Breast Cancer in African-American and European-American WomenChristine B Ambrosone, Gregory L Ciupak, Elisa V Bandera, et al.
Ebiomedicine|March 17, 2016
Gene by Environment Investigation of Incident Lung Cancer Risk in African-AmericansSean P David, Ange Wang, Kristopher Kapphahn, et al.
Pageof 7